{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:50:27Z","timestamp":1720173027370},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mce.2015.09.003","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T13:31:34Z","timestamp":1441632694000},"page":"10-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Combination cannabinoid and opioid receptor antagonists improves metabolic outcomes in obese mice"],"prefix":"10.1016","volume":"417","author":[{"given":"Sarah H.","family":"Lockie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Stefanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias H.","family":"Tsch\u00f6p","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mce.2015.09.003_bib1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A\u00a0randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obes. (Silver Spring)"},{"issue":"12","key":"10.1016\/j.mce.2015.09.003_bib2","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00125-011-2302-6","article-title":"Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice","volume":"54","author":"Bajzer","year":"2011","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.mce.2015.09.003_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nn.2494","article-title":"Bimodal control of stimulated food intake by the endocannabinoid system","volume":"13","author":"Bellocchio","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.mce.2015.09.003_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.conb.2011.09.004","article-title":"Metabolic and hedonic drives in the neural control of appetite: who is the boss?","volume":"21","author":"Berthoud","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.mce.2015.09.003_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.mce.2015.09.003_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/en.2011-1634","article-title":"Sex differences in the metabolic effects of testosterone in sheep","volume":"153","author":"Clarke","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.mce.2015.09.003_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/0031-9384(67)90045-5","article-title":"Relationship between gnawing and food consumption with ventromedial hypothalamic lesions","volume":"2","author":"Cox","year":"1967","journal-title":"Physiol. Behav."},{"issue":"15","key":"10.1016\/j.mce.2015.09.003_bib8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mce.2015.09.003_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1176\/jnp.9.3.382","article-title":"Neurobiology of fear responses: the role of the amygdala","volume":"9","author":"Davis","year":"1997","journal-title":"J.\u00a0Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.mce.2015.09.003_bib10","first-page":"30","article-title":"Nor-binaltorphimine \u2013 a potent and selective Kappa-Opioid receptor antagonist with long-lasting activity invivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch. Int. De Pharmacodyn. De Ther."},{"issue":"4","key":"10.1016\/j.mce.2015.09.003_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/BF00403900","article-title":"Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats","volume":"10","author":"Ernst","year":"1967","journal-title":"Psychopharmacologia"},{"issue":"9774","key":"10.1016\/j.mce.2015.09.003_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mce.2015.09.003_bib13","article-title":"The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance","volume":"19","author":"Jbilo","year":"2005","journal-title":"FASEB J."},{"issue":"4\u20135","key":"10.1016\/j.mce.2015.09.003_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresbull.2008.10.014","article-title":"Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2","volume":"78","author":"Jelsing","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.mce.2015.09.003_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-789X.2009.00581.x","article-title":"Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis","volume":"10","author":"Johansson","year":"2009","journal-title":"Obes. Rev."},{"issue":"10","key":"10.1016\/j.mce.2015.09.003_bib16","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/en.2011-1220","article-title":"CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice","volume":"152","author":"Lockie","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2015.09.003_bib17","first-page":"1","article-title":"Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances \u2018liking\u2019 of sweet reward","author":"Mahler","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.mce.2015.09.003_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.mce.2015.09.003_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2009.04.004","article-title":"The endocannabinoid system: role in glucose and energy metabolism","volume":"60","author":"Nogueiras","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"23\u201324","key":"10.1016\/j.mce.2015.09.003_bib20","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0024-3205(95)00174-5","article-title":"Biochemical and pharmacological characterization of SR141716A, the first potent and Selective brain cannabinoid receptor antagonist","volume":"56","author":"Rinaldi-Carmona","year":"1995","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.mce.2015.09.003_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1573405054038717","article-title":"fMRI of the emotions: towards an improved understanding of amygdala function","volume":"1","author":"Robinson","year":"2005","journal-title":"Curr. Med. Imaging Rev."},{"issue":"1","key":"10.1016\/j.mce.2015.09.003_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","volume":"26","author":"Ruehle","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"8","key":"10.1016\/j.mce.2015.09.003_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neuropharm.2004.08.008","article-title":"Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716","volume":"47","author":"Singh","year":"2004","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.mce.2015.09.003_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.mce.2015.09.003_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/oby.2008.509","article-title":"The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure","volume":"17","author":"Verty","year":"2009","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.mce.2015.09.003_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ijo.2012.35","article-title":"Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-inudced obese mice","volume":"37","author":"Verty","year":"2013","journal-title":"Int. J. Obes. (Lond)"},{"issue":"7","key":"10.1016\/j.mce.2015.09.003_bib27","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/en.2011-0004","article-title":"Impaired CNS leptin action is implicated in depression associated with obesity","volume":"152","author":"Yamada","year":"2011","journal-title":"Endocrinology"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715300691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715300691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:22:56Z","timestamp":1537363376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720715300691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":27,"alternative-id":["S0303720715300691"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2015.09.003","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination cannabinoid and opioid receptor antagonists improves metabolic outcomes in obese mice","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}